Literature DB >> 16684013

Treatment for all: a vision for the future.

M W Skinner1.   

Abstract

The World Federation of Hemophilia (WFH) has defined a new strategic plan which maps out where the organization is going and what it can do for our members. The plan embraces the vision of Treatment for All; i.e. one day, treatment will be available for all those with inherited bleeding disorders, regardless of where they live. Treatment for All means proper diagnosis, management, and care by a multidisciplinary team of trained specialists. It means safe, effective treatment products are available for all people with inherited bleeding disorders. It means expanding services beyond haemophilia, to those with von Willebrand's disease, rare factor deficiencies, and inherited platelet disorders. Today, more than 75% of the global bleeding disorders community receive either inadequate or no treatment whatsoever. Our mission is to improve treatment where it is limited or does not exist. At the same time, we must sustain the many gains we have achieved thus far. The challenge is immense. Making our vision a reality requires us to be focused and deliberate about the programmes we undertake and the commitments we make. Building on past strategic plans, this plan presents a vision for the continued success of the WFH over the next 3-5 years.

Entities:  

Mesh:

Year:  2006        PMID: 16684013     DOI: 10.1111/j.1365-2516.2006.01280.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  2 in total

1.  Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs.

Authors:  D M Karpf; M Kjalke; L Thim; H Agersø; E P Merricks; N Defriess; T C Nichols; M Ezban
Journal:  Haemophilia       Date:  2011-06-20       Impact factor: 4.287

2.  Management of dental extraction in patients with Haemophilia A and B: a report of 58 extractions.

Authors:  Andre Peisker; Gregor-Franziskus Raschke; Stefan Schultze-Mosgau
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.